Artiva Biotherapeutics, Inc. Contracts & Agreements

59 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Omnibus Amendment, dated February 3, 2022, by and between the Registrant and GC Cell Corporation
Artiva Biotherapeutics, Inc.
2024
Form of Common Stock Certificate
Stock Agreements
Artiva Biotherapeutics, Inc.
2024
Amended and Restated Investors Rights Agreement, dated February 22, 2021, by and among the Registrant and certain of its stockholders
Investor Rights Agreements
Artiva Biotherapeutics, Inc.
2024
Form of Indemnification Agreement by and between the Registrant and its directors and officers
Indemnification Agreements
Artiva Biotherapeutics, Inc.
2024
Artiva Biotherapeutics, Inc. 2020 Equity Incentive Plan, as amended
Bonus & Incentive Agreements
Artiva Biotherapeutics, Inc.
2024
Forms of Stock Option Grant Notice, Stock Option Grant Notice with Acceleration of Vesting, Option Agreement and Notice of Exercise under the Artiva Biotherapeutics, Inc. 2020...
Bonus & Incentive Agreements
Artiva Biotherapeutics, Inc.
2024
Artiva Biotherapeutics, Inc. 2024 Equity Incentive Plan
Bonus & Incentive Agreements
Artiva Biotherapeutics, Inc.
2024
Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise under the Artiva Biotherapeutics, Inc. 2024 Equity Incentive Plan
Bonus & Incentive Agreements
Artiva Biotherapeutics, Inc.
2024
Forms of Restricted Stock Unit Grant Notice and Award Agreement under the Artiva Biotherapeutics, Inc. 2024 Equity Incentive Plan
Bonus & Incentive Agreements
Artiva Biotherapeutics, Inc.
2024
Artiva Biotherapeutics, Inc. 2024 Employee Stock Purchase Plan
Stock Agreements
Artiva Biotherapeutics, Inc.
2024
Executive Employment Agreement, dated December 14, 2020, as amended, by and between the Registrant and Fred Aslan, M.D
Employment Agreements
Artiva Biotherapeutics, Inc.
2024
Employment Offer Letter, dated May 21, 2022, by and between the Registrant and Thorsten Graef, M.D., Ph.D
Employment Agreements
Artiva Biotherapeutics, Inc.
2024
Employment Offer Letter, dated August 27, 2020, as amended, by and between the Registrant and Jennifer Bush
Employment Agreements
Artiva Biotherapeutics, Inc.
2024
Office Lease, dated June 12, 2019, by and between the Registrant and AAT La Jolla Commons, LLC (as successor-in-interest to HSPFLa Jolla Commons I Investors LLC)
Lease Agreements
Artiva Biotherapeutics, Inc.
2024
Option and License Agreement, dated September 4, 2019, by and between the Registrant and GC Cell Corporation (f/k/a GC Lab Cell Corporation)
License Agreements
Artiva Biotherapeutics, Inc.
2024
Amendment No. 1 to Option and License Agreement, dated June 23, 2020, by and between the Registrant and GC Cell Corporation
License Agreements
Artiva Biotherapeutics, Inc.
2024
Master Agreement for Manufacturing Services, dated March 16, 2020, by and between the Registrant and GC Cell Corporation (f/k/a GC Lab Cell Corporation)
Services Agreements
Artiva Biotherapeutics, Inc.
2024
Amendment No. 1 to Master Agreement for Manufacturing Services, dated June 16, 2020, by and between the Registrant and GC Cell Corporation
Services Agreements
Artiva Biotherapeutics, Inc.
2024
Master Research Services Agreement, dated August 3, 2020, by and between the Registrant and GC Cell Corporation
Services Agreements
Artiva Biotherapeutics, Inc.
2024
Selected Product License Agreement (AB-101), dated November 21, 2019, by and between the Registrant and GC Cell Corporation
License Agreements
Artiva Biotherapeutics, Inc.
2024
Selected Product License Agreement (AB-201), dated September 29, 2020, by and between the Registrant and GC Cell Corporation
License Agreements
Artiva Biotherapeutics, Inc.
2024
Amendment to Selected Product License Agreement (AB-201), dated September 6, 2023, by and between the Registrant and GC Cell Corporation
License Agreements
Artiva Biotherapeutics, Inc.
2024
Employment Offer Letter, dated May 21, 2022, by and between the Registrant and Thorsten Graef, M.D., Ph.D
Employment Agreements
Artiva Biotherapeutics, Inc.
Biotechnology
CA
2022
First Amendment to License Agreement, dated May 9, 2022, by and between the Registrant and ARE-SD Region No. 37, LLC
License Agreements
Artiva Biotherapeutics, Inc.
Biotechnology
2022
Omnibus Amendment, dated February 3, 2022, by and between the Registrant and GC Cell Corporation
Artiva Biotherapeutics, Inc.
2022
Form of Underwriting Agreement
Underwriting Agreements
Artiva Biotherapeutics, Inc.
2022
Retention Agreement, dated September 21, 2021, by and between the Registrant and Dr. Jason Litten
Retention Agreements
Artiva Biotherapeutics, Inc.
Biotechnology
2022
Employment Offer Letter, dated December 7, 2021, by and between the Registrant and Christopher P. Horan
Employment Agreements
Artiva Biotherapeutics, Inc.
2022
Consulting Agreement, dated December 15, 2020, by and between the Registrant and Fred Aslan, M.D
Consulting Agreements
Artiva Biotherapeutics, Inc.
2022
Filing Fee Disclosure and Payment Methods (Note: To be filed as Exhibit 107 but encountered hyperlink issues)
Note Agreements
Artiva Biotherapeutics, Inc.
Biotechnology
2022
Form of Common Stock Certificate
Stock Agreements
Artiva Biotherapeutics, Inc.
Biotechnology
2021
Artiva Biotherapeutics, Inc. 2022 Equity Incentive Plan
Bonus & Incentive Agreements
Artiva Biotherapeutics, Inc.
2021
Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise under the Artiva Biotherapeutics, Inc. 2022 Equity Incentive Plan
Bonus & Incentive Agreements
Artiva Biotherapeutics, Inc.
Biotechnology
2021
Artiva Biotherapeutics, Inc. 2022 Employee Stock Purchase Plan
Stock Agreements
Artiva Biotherapeutics, Inc.
Biotechnology
2021
Non-Employee Director Compensation Policy
Compensation Agreements
Artiva Biotherapeutics, Inc.
2021
Separation Agreement, dated October 15, 2021, by and between the Registrant and Thomas J. Farrell
Separation Agreements
Artiva Biotherapeutics, Inc.
2021
Amendment No. 1 to Strategic Collaboration Agreement, dated October 18, 2021, by and between the Registrant and Affimed GmbH
Collaboration Agreements
Artiva Biotherapeutics, Inc.
Biotechnology
2021
Amended and Restated Investors Rights Agreement, dated February 22, 2021, by and among the Registrant and certain of its stockholders
Investor Rights Agreements
Artiva Biotherapeutics, Inc.
Biotechnology
DE
2021
Form of Indemnification Agreement by and between the Registrant and its directors and officers
Indemnification Agreements
Artiva Biotherapeutics, Inc.
2021
Artiva Biotherapeutics, Inc. 2020 Equity Incentive Plan, as amended
Bonus & Incentive Agreements
Artiva Biotherapeutics, Inc.
Biotechnology
DE
2021
Forms of Stock Option Grant Notice, Stock Option Grant Notice with Acceleration of Vesting, Option Agreement and Notice of Exercise under the Artiva Biotherapeutics, Inc. 2020...
Bonus & Incentive Agreements
Artiva Biotherapeutics, Inc.
Biotechnology
2021
Executive Employment Agreement, dated December 14, 2020, as amended, by and between the Registrant and Fred Aslan, M.D
Employment Agreements
Artiva Biotherapeutics, Inc.
2021
Executive Employment Agreement, dated March 1, 2019, as amended, by and between the Registrant and Thomas J. Farrell
Employment Agreements
Artiva Biotherapeutics, Inc.
Biotechnology
DE
2021
Employment Offer Letter, dated March 16, 2019, as amended, by and between the Registrant and Dr. Peter Flynn
Employment Agreements
Artiva Biotherapeutics, Inc.
Biotechnology
CA
2021
Employment Offer Letter, dated August 11, 2019, as amended, by and between the Registrant and Dr. Jason Litten
Employment Agreements
Artiva Biotherapeutics, Inc.
2021
Employment Offer Letter, dated August 24, 2020, as amended, by and between the Registrant and Jennifer Bush
Employment Agreements
Artiva Biotherapeutics, Inc.
Biotechnology
CA
2021
Employment Offer Letter, dated March 22, 2021, by and between the Registrant and Michael E. Faerm
Employment Agreements
Artiva Biotherapeutics, Inc.
Biotechnology
CA
2021
Office Lease, dated June 12, 2019, by and between the Registrant and AAT La Jolla Commons, LLC (as successor-in-interest to HSPF La Jolla Commons I Investors LLC)
Lease Agreements
Artiva Biotherapeutics, Inc.
2021
Option and License Agreement, dated September 4, 2019, by and between the Registrant and Green Cross LabCell Corporation
License Agreements
Artiva Biotherapeutics, Inc.
2021
Amendment No. 1 to Option and License Agreement, dated June 23, 2020, by and between the Registrant and Green Cross LabCell Corporation
License Agreements
Artiva Biotherapeutics, Inc.
Biotechnology
2021
Master Agreement for Manufacturing Services, dated March 16, 2020, by and between the Registrant and Green Cross Cell Corporation
Services Agreements
Artiva Biotherapeutics, Inc.
2021
Amendment No. 1 to Master Agreement for Manufacturing Services, dated June 16, 2020, by and between the Registrant and Green Cross Cell Corporation
Services Agreements
Artiva Biotherapeutics, Inc.
2021
Master Research Services Agreement, dated August 3, 2020, by and between the Registrant and Green Cross LabCell Corporation
Services Agreements
Artiva Biotherapeutics, Inc.
2021
Selected Product License Agreement (AB-101), dated November 21, 2019, by and between the Registrant and Green Cross LabCell Corporation
License Agreements
Artiva Biotherapeutics, Inc.
2021
Selected Product License Agreement (AB-201), dated September 29, 2020, by and between the Registrant and Green Cross LabCell Corporation
License Agreements
Artiva Biotherapeutics, Inc.
2021
Exclusive License and Collaboration Agreement, dated January 27, 2021, by and between the Registrant and Merck Sharp & Dohme Corp
Collaboration Agreements
Artiva Biotherapeutics, Inc.
Biotechnology
NY
2021
Merck Partnered Product Research Services and License Agreement, dated January 27, 2021, by and between the Registrant and Green Cross LabCell Corporation
License Agreements
Artiva Biotherapeutics, Inc.
Biotechnology
NY
2021
Strategic Collaboration Agreement, dated November 5, 2020, by and between the Company and Affimed GmbH
Collaboration Agreements
Artiva Biotherapeutics, Inc.
Biotechnology
NY
2021
Selected Product License Agreement (AB-202), dated March 24, 2021, by and between the Registrant and Green Cross LabCell Corporation
License Agreements
Artiva Biotherapeutics, Inc.
Biotechnology
2021